| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 69 |
| 1 | ERGOCALCIFEROL | 57 |
| 2 | PAROXETINE HYDROCHLORIDE | 51 |
| 3 | IPRATROPIUM BROMIDE | 50 |
| 4 | MONTELUKAST SODIUM | 50 |
| 5 | CICLESONIDE | 49 |
| 6 | VALSARTAN | 49 |
| 7 | VALSARTAN ORAL | 49 |
| 8 | DULOXETINE | 46 |
| 9 | DULOXETINE HYDROCHLORIDE | 46 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE | 1 | 0.0244 |
| 1 | BUPROPION HYDROBROMIDE | 13 | 0.0225 |
| 2 | VELMANASE ALFA-TYCV | 1 | 0.0179 |
| 3 | NAFARELIN ACETATE | 2 | 0.0073 |
| 4 | TRANDOLAPRIL TABLETS | 10 | 0.0049 |
| 5 | GLYCOPYRROLATE | 25 | 0.0044 |
| 6 | THEOPHYLLINE ANHYDROUS | 45 | 0.0036 |
| 7 | CICLESONIDE | 49 | 0.0036 |
| 8 | VON WILLEBRAND FACTOR (RECOMBINANT) | 1 | 0.0032 |
| 9 | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 1 | 0.0032 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 88 |
| 1 | Estrogen [EPC] | 70 |
| 2 | Provitamin D2 Compound [EPC] | 57 |
| 3 | Angiotensin 2 Receptor Blocker [EPC] | 50 |
| 4 | Methylxanthine [EPC] | 49 |
| 5 | Progestin [EPC] | 44 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 38 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 36 |
| 8 | Proton Pump Inhibitor [EPC] | 31 |
| 9 | Expectorant [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 5 | 0.0024 |
| 1 | Provitamin D2 Compound [EPC] | 57 | 0.0019 |
| 2 | Methylxanthine [EPC] | 49 | 0.0008 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 10 | 0.0005 |
| 4 | Leukotriene Receptor Antagonist [EPC] | 14 | 0.0005 |
| 5 | Copper-containing Intrauterine Device [EPC] | 19 | 0.0004 |
| 6 | Estrogen [EPC] | 70 | 0.0004 |
| 7 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 8 | Progesterone [EPC] | 5 | 0.0002 |
| 9 | Chloride Channel Activator [EPC] | 2 | 0.0002 |